ZimVie Introduces Two New RegenerOss Products to Market

ZimVie Inc. has recently launched two additions to its biomaterials portfolio: RegenerOss CC Allograft Particulate and RegenerOss Bone Graft Plug.

The RegenerOss CC Allograft Particulate is a natural blend of cortical and cancellous bone particles for filling bony voids in various dental applications. The graft has been sterilized and freeze-dried using the Cancelle SP Sterilization Process, a proprietary method for cleansing and preserving the graft.  

ZimVie’s RegenerOss Bone Graft Plug is an easy-to-use grafting solution for filling extraction sockets and periodontal defects. The Plug is a combination of 80% graft particulate and 20% Type I bovine collagen that adapts to the shape of the defect once hydrated.

“We are continuing to innovate and build on the core strengths of our dental portfolio through next-generation premium implants and abutments, additional modules within our digital dentistry suite, and now an expanded solution set in biomaterials,” said Indraneel Kanaglekar, senior vice president and president of ZimVie Dental. “Our RegenerOss solutions provide greater options to customers and patients, and nicely complement our existing offering of clinically successful bone grafts.” 
 
These launches broaden ZimVie’s presence in the dental biomaterials market and expand the company’s suite of bone graft offerings, which also includes the Puros Allograft line. ZimVie will continue to feature the Puros Allograft Particulate with its history of clinical results alongside the RegenerOss line of grafting solutions. Dental bone graft procedures are done to repair or reconstruct the jaw and can provide a foundation for dental implant placement.
 
Puros Allograft and RegenerOss CC Allograft Particulate are processed by RTI Surgical Inc. and marketed by Biomet 3i LLC (ZimVie Dental), its affiliates, and authorized marketing partners. RegenerOss Bone Graft Plug is marketed by Biomet 3i LLC, its affiliates, and authorized marketing partners. 
 
ZimVie is a global life sciences leader in the dental and spine markets that develops, manufactures, and delivers a portfolio of products and solutions designed to treat a wide range of spine pathologies and support dental tooth replacement and restoration procedures. The company was founded in March 2022 as an independent, publicly traded spin-off of the Dental and Spine business units of Zimmer Biomet. From its Westminster, Colo. headquarters and additional facilities worldwide, the company serves customers in more than 70 countries with dental and spine solutions, including differentiated product platforms supported by extensive clinical evidence.